CanSino Biologics leads slide in vaccine makers as China eases COVID curbs

Cansino Biologics

05/12/2022 04:33

** CanSino Biologics'  688185.SS  Shanghai stock leads slide
in vaccine makers, falling as much as 8.9% to 186.80 yuan, their
lowest since Nov. 1
    ** Hong Kong shares  6185.HK  of the producer of recombinant
COVID-19 Vaccine for Inhalation fall 6.1% 
    ** More Chinese cities announced an easing of coronavirus
curbs on Sunday as China tries to make its zero-COVID policy
more targeted and less onerous after unprecedented protests
against restrictions last weekend  urn:newsml:reuters.com:*:nL1N32U016 urn:newsml:reuters.com:*:nB9N31Y02H
    ** Brokers say anticipation of weakening demand for vaccine
and test kit as more Chinese cities ease COVID-19 curbs put
pressure on related sectors
    ** "It provides a good opportunity for the related shares to
undergo adjustment after their recent strength, while easing
curbs is generally positive for the whole market," said Steven
Leung, a sales director at UOB Kay Hian
    ** Shares of vaccine maker Chongqing Zhifei Biological
Products  300122.SZ  fall 4.6% 
    ** Stock of Clover Biopharmaceuticals  2197.HK , which
jumped 21% in early trade after it said its COVID-19 vaccine has
been included for emergency use in China, trims gains later to
HK$4.76, still up 7.7% 
    ** Shares of Chinese test kit makers Andon Health
 002432.SZ , Wantai  603392.SS , Vazyme  688105.SS , Wondfo
 300482.SZ  and Hotgen  688068.SS  drop between 1.8% and 8.1%
    ** Hang Seng Index  .HSI  rises 3.2%
 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))